| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K07442505 |
| PharmacoGx | BRD-K07442505 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PODN | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | RGS12 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ZFYVE19 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | FXYD4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | DDX21 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | ZC3H3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CSTF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | GATSL3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | NUF2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | ATP13A5 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
